| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2008 | WO2008154470A1 Nhibitor of the receptor activity of the s1p2 receptor for inhibiting pathological angiogenesis in the eye |
| 12/18/2008 | WO2008154469A1 Quinazoline salt compounds |
| 12/18/2008 | WO2008154457A1 Topiramate immunoassays |
| 12/18/2008 | WO2008154447A1 Therapeutic pyrazolonaphthyridine derivatives |
| 12/18/2008 | WO2008154442A1 Therapeutic pyrazoloquinoline urea derivatives |
| 12/18/2008 | WO2008154438A1 Therapeutic pyrazoloquinoline derivatives |
| 12/18/2008 | WO2008154402A2 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 12/18/2008 | WO2008154389A1 Aldosterone induced elastin production |
| 12/18/2008 | WO2008154382A1 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 12/18/2008 | WO2008154373A1 2-amino-2,7-dideoxy-alpha-d-glycero-d-gluco-heptopyranosyl inhibitors of positive sense single-stranded rna envelope viruses |
| 12/18/2008 | WO2008154372A1 Mutual prodrugs and methods to treat cancer |
| 12/18/2008 | WO2008154368A2 Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof |
| 12/18/2008 | WO2008154353A1 Thalidomide analogs for treating vascular abnormalities |
| 12/18/2008 | WO2008154347A1 Spirobenzoazepines as vasopressin antagonists |
| 12/18/2008 | WO2008154323A1 REGULATION OF sGC FUNCTION BY CORRIN DERIVATIVES |
| 12/18/2008 | WO2008154286A2 Modulation of chemosensory receptors and ligands associated therewith |
| 12/18/2008 | WO2008154271A1 Chemical compounds |
| 12/18/2008 | WO2008154262A1 Stabilized amorphous forms of imatinib mesylate |
| 12/18/2008 | WO2008154259A1 Biphenylcarboxamide derivatives as hedgehog pathway modulators |
| 12/18/2008 | WO2008154246A1 Hiv integrase inhibitors |
| 12/18/2008 | WO2008154221A2 Modulation of chemosensory receptors and ligands associated therewith |
| 12/18/2008 | WO2008154141A2 Compositions and methods for preventing, minimizing and healing skin irritation and trauma |
| 12/18/2008 | WO2008154136A1 Compositions and methods for modulating inflammation using fluoroquinolones |
| 12/18/2008 | WO2008154129A1 Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye |
| 12/18/2008 | WO2008154126A1 New heteocyclic h3 antagonists |
| 12/18/2008 | WO2008154107A1 Self-healing polymer compositions |
| 12/18/2008 | WO2008154083A2 Compounds, compositions and methods for the treatment of synucleinopathies |
| 12/18/2008 | WO2008154044A1 Therapeutic compounds and methods of use |
| 12/18/2008 | WO2008154026A1 Substituted pyrazole compounds |
| 12/18/2008 | WO2008154023A1 Novel uses of ppar delta agonists |
| 12/18/2008 | WO2008154008A1 Methods and compositions for inhibiting toll-like receptor mediated immune responses |
| 12/18/2008 | WO2008153997A1 Reduced-mass, long-acting dosage forms |
| 12/18/2008 | WO2008153974A1 Novel heterocycle compounds and uses thereof |
| 12/18/2008 | WO2008153966A1 Mucoadhesive vesicles for drug delivery |
| 12/18/2008 | WO2008153959A1 Novel heterocycle compounds and uses thereof |
| 12/18/2008 | WO2008153958A2 Crystalline forms of (r)-1-{2-[4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 12/18/2008 | WO2008153957A1 Uses of rage antagonists for treating obesity and related diseases |
| 12/18/2008 | WO2008153947A2 Heterocyclic compounds as raf kinase modulators |
| 12/18/2008 | WO2008153945A2 Nutraceutical co-crystal compositions |
| 12/18/2008 | WO2008153942A1 Kinase inhibitor compounds |
| 12/18/2008 | WO2008153937A2 Novel 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| 12/18/2008 | WO2008153902A2 Urotensin ii receptor antagonists |
| 12/18/2008 | WO2008153900A1 Kinase inhibitor compounds |
| 12/18/2008 | WO2008153884A1 Compositions useful for treating gastroesophageal reflux disease |
| 12/18/2008 | WO2008153882A1 Benefit agent containing delivery particle |
| 12/18/2008 | WO2008153858A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
| 12/18/2008 | WO2008153857A1 Dual-acting benzoimidazole antihypertensive agents |
| 12/18/2008 | WO2008153849A1 Carboxamide heterocyclic cgrp receptor antagonists |
| 12/18/2008 | WO2008153793A2 Gamma secretase modulators |
| 12/18/2008 | WO2008153792A2 Gamma secretase modulators |
| 12/18/2008 | WO2008153779A1 Spiro and other derivatives of diamondoids possessing therapeutic activity in the treatment of viral disorders |
| 12/18/2008 | WO2008153778A1 Diamondoid derivatives possessing therapeutic activity in the treatment of viral disorders |
| 12/18/2008 | WO2008153771A1 Methods and compositions for treating phenylketonuria |
| 12/18/2008 | WO2008153767A2 Release coating composition and method of forming the same |
| 12/18/2008 | WO2008153761A1 Methods |
| 12/18/2008 | WO2008153752A2 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 12/18/2008 | WO2008153746A1 Formulations and methods for treating dry eye |
| 12/18/2008 | WO2008153730A2 Method for treating proliferative disorders associated with mutations in c-met |
| 12/18/2008 | WO2008153722A1 Post-translational regulation of catalytic activities of cytochrome p450 46a1 and uses thereof |
| 12/18/2008 | WO2008153632A2 Compositions and methods for treating obesity and related disorders |
| 12/18/2008 | WO2008153611A2 Sustained delivery formulations of risperidone compounds |
| 12/18/2008 | WO2008153582A1 Concentrate esmolol |
| 12/18/2008 | WO2008153511A1 The use of disulfiram in the treatment of gastrointestinal system ulcers |
| 12/18/2008 | WO2008153443A1 Method for bio-controllable photo-dynamic therapy |
| 12/18/2008 | WO2008153426A1 Anti-inflammatory composition and use thereof |
| 12/18/2008 | WO2008153421A1 Anticancer therapies |
| 12/18/2008 | WO2008153394A2 Novel anti-inflammatory pro-drugs |
| 12/18/2008 | WO2008153391A2 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
| 12/18/2008 | WO2008153385A1 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases |
| 12/18/2008 | WO2008153377A1 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
| 12/18/2008 | WO2008153374A1 Pharmaceutical composition combining an enzyme hmg-coa reductase inhibiting agent and a gastrointestinal lipase enzyme inhibiting agent |
| 12/18/2008 | WO2008153319A1 Transglutaminase inhibitor comprising egcg and a method for producing thereof |
| 12/18/2008 | WO2008153318A2 Transglutaminase inhibitor comprising chlorogenic acid and a method for producing thereof |
| 12/18/2008 | WO2008153282A1 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound |
| 12/18/2008 | WO2008153220A1 Prophylactic or therapeutic agent for vascular disease |
| 12/18/2008 | WO2008153207A1 Bicycloaniline derivative |
| 12/18/2008 | WO2008153182A1 Morpholine derivative |
| 12/18/2008 | WO2008153159A1 Amine compound and pharmaceutical use thereof |
| 12/18/2008 | WO2008153158A1 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food |
| 12/18/2008 | WO2008153135A1 Naphthalene derivative |
| 12/18/2008 | WO2008153129A1 Agent for lowering uric acid level |
| 12/18/2008 | WO2008153091A1 Screening method |
| 12/18/2008 | WO2008153077A1 Anti-norovirus agent, and composition comprising the same |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |
| 12/18/2008 | WO2008153042A1 Anti-tumor agent |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008152764A1 Pharmaceutical composition |
| 12/18/2008 | WO2008152758A1 Therapeutic agent for malignant tumor derived from alpinia officinarum rhizome |
| 12/18/2008 | WO2008152753A1 Novel crystal of 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1h-benzimidazole sodium salt and process for producing the same |
| 12/18/2008 | WO2008152729A1 Jelly-like pharmaceutical composition containing risperidone |
| 12/18/2008 | WO2008152619A1 Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives |
| 12/18/2008 | WO2008152603A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 12/18/2008 | WO2008152598A1 Stabilized pharmaceutical compositions comprising atorvastatin |
| 12/18/2008 | WO2008152471A1 Quinazoline derivative useful as toll-like receptor antagonist |
| 12/18/2008 | WO2008152423A2 Treatment of inflammation or autoimmune diseases with sulphated compounds |
| 12/18/2008 | WO2008152421A2 Modification of cytokine levels with glucosylamine compounds |
| 12/18/2008 | WO2008152420A1 New compounds 892 |
| 12/18/2008 | WO2008152398A2 Formulations for inhalation |
| 12/18/2008 | WO2008152394A1 Pharmaceutical compounds |
| 12/18/2008 | WO2008152390A1 Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |